(Q34744189)

English

Effect of hemodialysis on plasma glucose profile and plasma level of liraglutide in patients with type 2 diabetes mellitus and end-stage renal disease: a pilot study

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

4 August 2017

Effect of hemodialysis on plasma glucose profile and plasma level of liraglutide in patients with type 2 diabetes mellitus and end-stage renal disease: a pilot study (English)

1 reference

Europe PubMed Central

4 August 2017

type 2 diabetes

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Takeshi Osonoi

1

1 reference

Europe PubMed Central

4 August 2017

Miyoko Saito

2

1 reference

Europe PubMed Central

4 August 2017

Atsuko Tamasawa

3

1 reference

Europe PubMed Central

4 August 2017

Hidenori Ishida

4

1 reference

Europe PubMed Central

4 August 2017

Daisuke Tsujino

5

1 reference

Europe PubMed Central

4 August 2017

Rimei Nishimura

6

1 reference

Europe PubMed Central

4 August 2017

Kazunori Utsunomiya

7

1 reference

Europe PubMed Central

4 August 2017

language of work or name

0 references

publication date

19 December 2014

1 reference

Europe PubMed Central

4 August 2017

1 reference

Europe PubMed Central

4 August 2017

9

1 reference

Europe PubMed Central

4 August 2017

12

1 reference

Europe PubMed Central

4 August 2017

e113468

1 reference

Europe PubMed Central

4 August 2017

copyright license

Creative Commons Attribution 4.0 International

19 December 2014

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

The efficacy of incretin therapy in patients with type 2 diabetes undergoing hemodialysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4272272

7 July 2018

Long-term efficacy and safety comparison of liraglutide, glimepiride and placebo, all in combination with metformin in type 2 diabetes: 2-year results from the LEAD-2 study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4272272

7 July 2018

Liraglutide: a review of the first once-daily GLP-1 receptor agonist.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4272272

7 July 2018

Pharmacology, efficacy and safety of liraglutide in the management of type 2 diabetes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4272272

7 July 2018

Antidiabetic agents in patients with chronic kidney disease and end-stage renal disease on dialysis: metabolism and clinical practice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4272272

7 July 2018

Early clinical studies with liraglutide

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4272272

7 July 2018

Effect of renal impairment on the pharmacokinetics of the GLP-1 analogue liraglutide

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4272272

7 July 2018

Effect of renal impairment on the pharmacokinetics of exenatide

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4272272

7 July 2018

Inter-day glycemic variability assessed by continuous glucose monitoring in insulin-treated type 2 diabetes patients on hemodialysis

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0113468

21 January 2018

Metabolism and excretion of the once-daily human glucagon-like peptide-1 analog liraglutide in healthy male subjects and its in vitro degradation by dipeptidyl peptidase IV and neutral endopeptidase

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0113468

21 January 2018

Prolonged sulfonylurea-induced hypoglycemia in diabetic patients with end-stage renal disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/25526642

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Liraglutide narrows the range of circadian glycemic variations in Japanese type 2 diabetes patients and nearly flattens these variations in drug-naive type 2 diabetes patients: a continuous glucose monitoring-based study

1 reference

https://pubmed.ncbi.nlm.nih.gov/25526642

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1371/JOURNAL.PONE.0113468

1 reference

Europe PubMed Central

4 August 2017

2014PLoSO...9k3468O

0 references

1 reference

Europe PubMed Central

4 August 2017

1 reference

Europe PubMed Central

4 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34744189&oldid=1859049059"